COMPANY OVERVIEW

Founded 125 years ago by Chicago physician Dr. Wallace C. Abbott, Abbott has emerged as one of the largest diversified global healthcare companies, with $22 billion in sales across 150 countries and ~60,000 employees around the world.

Abbott has been operating since 1910 in India and provides consumers with a diverse range of established pharmaceutical, nutritional products, medical products, and diagnostic tests.

COMPANY FACTS Primary activities: Manufacturing, research and development, sales and marketing

Sites: Pharmaceutical Manufacturing: Baddi and Goa

Pharmaceutical Research and Development: Mumbai and Baddi

Nutrition Research and Development: Bangalore

Employees: Over 12,000

History: Has operated in India for more than 100 years

Awards: • Frost & Sullivan Healthcare Excellence Award ‘Multinational Corporation Pharmaceutical Company of the year’ in 2011 and 2012.

• ‘India’s Most Admired Nutrition & Nutraceutical Company’ in 2011 by Pharmaleaders.

Website: www.abbott.co.in

ABBOTT IN INDIA

Abbott is the number-one pharmaceutical company and one of the leading healthcare companies in India. Abbott’s products and services encircle life from newborns to aging adults, addressing the full range of their healthcare needs from disease prevention and diagnosis to treatment and cure.

COMMUNITY INVOLVEMENT:

Global citizenship is an integral part of Abbott's mission to improve people's lives, focused on four key areas: innovating for the future, enhancing access to health care, safeguarding the environment, and protecting patients and consumers. Working in partnership with others, Abbott leverages its core business expertise and resources to create sustainable solutions in India and countries globally. To date, Abbott and its philanthropic foundation the Abbott Fund have provided nearly Rs. 61 crores [$12 million] in grants, donations and social innovation projects, impacting the lives of more than 15 Lakh [1.5 million] Indians.

OUR PRODUCTS ADDRESSING CRITICAL MEDICAL NEEDS:

A comprehensive portfolio of more than 400 brands, a strong infrastructure and large scale operations with therapeutic areas that include: women's health, neuropsychiatry, hepatic care, metabolics, pain, gastroenterology, cardiovascular and anti-infectives.

Key products include: Thyronorm® (hypothyroidism), Eptoin® (epilepsy/convulsions), Digene® (antacid), Duphaston® (progesterone deficiencies) Vertin® (vertigo), Udiliv® (cholestatic liver diseases), Duphalac® (constipation), Stemetil® (vertigo), Prothiaden® (depression) and Tribet® (diabetes).

Abbott offers a variety of nutritional products for infants, children, active adults and people with special dietary needs.

Key products currently available in India include: Similac® (milk formula for infants and children), PediaSure® (complete, balanced nutrition for children), Ensure® (adult nutritionals), Glucerna® (nutrition for people with diabetes), Nepro® (nutrition for people with kidney diseases), Prosure® (nutrition for people with cancer), and Mama’s Best® (nutritional supplement for pregnant and breastfeeding mothers).

Lines of business include vascular, diagnostics, diabetes care and vision care.

Key products include: the XIENCE V™ drug-eluting stent, laboratory diagnostic instruments ARCHITECT® and AxSYM®, and blood glucose monitoring devices for diabetes, FreeStyle Optium™ and FreeStyle Freedom Lite™. Abbott's vision care business provides cataract, refractive and corneal care products, including TECNIS® monofocal and multifocal intraocular lenses.

Medical Products

Pharmaceuticals

Nutritional Products